Pharma C Investments - Result of Aquis Disciplinary Investigation

Announcement provided by

10/08/2023 07:00

RNS Number : 8561I

Pharma C Investments PLC

10 August 2023

Result of Aquis Disciplinary Investigation

Pharma C Investments Plc ("Pharma C" or the "Company") confirms that Aquis Stock Exchange has imposed a public censure and a fine of £30,000 on the Company. Full details can be found in the Disciplinary Notice (see link below).

https://www.aquis.eu/stock-exchange/rules-and-regulations/market-notices

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

The Directors of Pharma C accept responsibility for this announcement.

END

For additional information please contact:

Pharma C Investments

Gavin Sathianathan, Investment Strategy Director

gavin@pharmacinvestments.com

Novum Securities (AQSE Corporate Adviser)

Tel: +44 207 399 9400

David Coffman

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXNKCBPABKDCFK ]]>

MCAI announcements All announcements